This compound is a pharmaceutical intermediate used in the synthesis of valsartan, specifically identified as valsartan impurity D. It features an aromatic nitrile and ester functional groups, and its structure is defined by a stereocenter.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Valsartan impurity D?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]-L-valine methyl ester hydrochloride
pharmaceutical intermediate
N-(2-Benzoyl-4-chlorophenyl)acetamide
pharmaceutical intermediate
1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethanone
pharmaceutical intermediate
N-Acetyl-N-(2-(7-methoxynaphthalen-1-yl)ethyl)acetamide
pharmaceutical intermediate
Methyl 2-chloro-3-nitropyridine-4-carboxylate
pharmaceutical intermediate
methyl (2S)-2-[[4-(2-cyanophenyl)phenyl]methylamino]-3-methylbutanoate
ZQHINOUCNQKQEV-IBGZPJMESA-N
CC(C)[C@@H](C(=O)OC)NCC1=CC=C(C=C1)C2=CC=CC=C2C#N
Sourcing Valsartan impurity D?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.